Katerina Gelezhe

Dr. Katerina Gelezhe

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
KGKaterina Gelezhe
Katerina Gelezhe
AKA.V. Kudryavtseva
A.V. Kudryavtseva
OSOksana Svitich
Oksana Svitich
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.

17 July 2025 in Life
Verified
Journal Article
Open access
PDF file
AKAsya Kudryavtseva
Asya Kudryavtseva
FFFyodor Fluer
Fyodor Fluer
LKLusine Khachatryan
Lusine Khachatryan
SMSvetlana Makarova
Svetlana Makarova
OOOksana Osipenko
Oksana Osipenko
KGKaterina Gelezhe
Katerina Gelezhe
Staphylococcus spp. skin colonization is involved in the pathogenesis of atopic dermatitis (AD). While coagulase-positive Staphylococcus aureus strains are known to worsen symptoms, the role of coagulase-negative staphylococci (CoNS) remains controversial. Further research is needed to clarify the pathogenicity of CoNS in AD patients. A study involving 329 children with AD (mean age: 4.89 years) assessed the frequency of staphylococcal colonization on affected skin, along with the toxin-producing properties and antibiotic resistance of isolated strains. Mild AD: Predominantly colonized by CoNS (especially S. epidermidis). Moderate/Severe AD: Showed a significant increase in S. aureus colonization. CoNS (including S. epidermidis) could produce enterotoxins (A, B, C) and toxic shock syndrome toxin-1 (TSST-1), though less frequently than S. aureus strains. In severe AD, the number of toxin-producing CoNS strains (especially enterotoxin A producers) was higher than in mild AD, and the number of non-toxin-producing strains was lower. CoNS exhibited higher resistance rates than S. aureus. Methicillin-resistant S. epidermidis (MRSE): 23.4%. Methicillin-resistant S. aureus (MRSA): 1.27%. CoNS may contribute to AD pathogenesis through toxin production (exacerbating inflammation) and antibiotic resistance (limiting treatment options). Severe AD may involve a synergistic effect between S. aureus and toxin-producing CoNS.

1 January 2022 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
OSOksana Svitich
Oksana Svitich
VSVictoria Soboleva
Victoria Soboleva
NAN.D. Abramova
N.D. Abramova
KGKaterina Gelezhe
Katerina Gelezhe
AKA.V. Kudryavtseva
A.V. Kudryavtseva
The expression of innate immune genes, defensins, changes in atopic dermatitis (AD). There has been much research on β-defensins, whereas the role of α-defensins in AD has not been adequately examined. Objective. To evaluate the expression of HNP1 gene in affected and visually unaffected skin areas in patients with different clinical and morphological forms of AD. Patients and methods. The participants in this study (n = 103) were patients admitted to the Maternity and Childhood Center of Sechenov University in 2020–2022. Two skin scraping samples were obtained from each of the patients with AD (n = 89), from skin areas affected and not affected by AD; one skin scraping sample was obtained from control group participants (n = 14) with no skin diseases. To determine the expression of HNP1 in skin cells, a real-time reverse transcription polymerase chain reaction followed by statistical analysis was performed. Results. A significant increase in the expression of HNP1 gene was demonstrated in a more severe course of AD with the development of lichenoid skin changes. The elevated expression level of this antimicrobial peptide indicates the development of inflammatory reactions involving neutrophils in the inflammation area, possibly associated with colonization of the affected skin by opportunistic bacterial pathogens. Conclusion. The α-defensin HNP1 plays an important role in disease progression and can subsequently be used in the treatment of AD as a highly effective alternative approach. Key words: atopic dermatitis, children, neutrophil peptide 1, HNP1

12 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AKAsya Kudryavtseva
Asya Kudryavtseva
FFFyodor Fluer
Fyodor Fluer
LKLusine Khachatryan
Lusine Khachatryan
SMSvetlana Makarova
Svetlana Makarova
OOOksana Osipenko
Oksana Osipenko
KGKaterina Gelezhe
Katerina Gelezhe
Staphylococcus spp. skin colonization is involved in the pathogenesis of atopic dermatitis (AD). While coagulase-positive Staphylococcus (S.) aureus strains are known to worsen symptoms, the role of coagulase-negative staphylococci (CoNS) remains controversial. Further research is needed to clarify the pathogenicity of CoNS in AD patients. A study involving 329 children with AD (mean age: 4.89 years) assessed the frequency of staphylococcal colonization on affected skin, along with the toxin-producing properties and antibiotic resistance of isolated strains. Mild AD: Predominantly colonized by CoNS (especially S. epidermidis). Moderate/Severe AD: Showed a significant increase in S. aureus colonization. CoNS (including S. epidermidis) could produce enterotoxins (A, B, C) and toxic shock syndrome toxin-1 (TSST-1), though less frequently than S. aureus strains. In severe AD, toxin-producing CoNS strains (particularly enterotoxin A producers) were more common than non-toxin-producing strains, suggesting a possible aggravation of inflammation via superantigen-mediated mechanism. CoNS exhibited higher resistance rates than S. aureus. Methicillin-resistance S. epidermidis (MRSE): 23.4%. Methicillin-resistance S. aureus (MRSA): 1.27%. This indicates that CoNS in AD may act as a reservoir for antibiotic resistance genes, complicating treatment. CoNS may contribute to AD pathogenesis through toxin production (exacerbating inflammation) and antibiotic resistance (limiting treatment options). Severe AD may involve a synergistic effect between S. aureus and toxin-producing CoNS.